XENE — Xenon Pharmaceuticals Inc · $2.55B cap

Xenon Pharmaceuticals Inc (XENE) is a biotechnology company listed on US.

Latest reported XENE revenue for 2026-06-30 was $0. Net income was -$213.0M. XENE currently screens at market cap $2.55B.

Use this XENE page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the XENE quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the XENE SEC filings page. Lician reads the product cache first so this HTML stays unique to Xenon Pharmaceuticals Inc even when a live quote feed is slow.

Xenon Pharmaceuticals Inc latest statements (FY2025)

Latest cached year on this hub. Full XENE income, balance, and cash tables.

  • Revenue$7.5M
  • Net Income-$345.9M
  • Total Assets$633.2M
  • Total Debt$0
  • Free Cash Flow-$279.9M